BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34313744)

  • 21. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
    Chen J; Wang A; Ji K; Bu Z; Ji J
    BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
    Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
    Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
    Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
    Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report.
    Yang G; Li D; Zheng F; Yang L
    Mol Clin Oncol; 2018 May; 8(5):653-656. PubMed ID: 29732153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component.
    Yamaguchi E; Sato Y; Oe T; Nishi T; Koike M; Kitakado Y; Takubo K
    Clin J Gastroenterol; 2015 Apr; 8(2):82-7. PubMed ID: 25823931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.
    Yang H; Yang Y; Dou J; Cui R; Cheng Z; Han Z; Liu F; Yu X; Zhou X; Yu J; Liang P
    Cancer Biol Med; 2020 May; 17(2):478-491. PubMed ID: 32587783
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma.
    Nakanishi Y; Ohara M; Domen H; Shichinohe T; Hirano S; Ishizaka M
    World J Surg Oncol; 2013 May; 11():98. PubMed ID: 23683476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological features and prognosis of patients with gastric neuroendocrine carcinoma from multiple centers in southern China].
    Fang C; Wang W; Zhang Y; Feng X; Zeng Y; Li Y; Chen J; Chen Y; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1230-1234. PubMed ID: 27928791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
    Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
    Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study.
    Mokadem I; Dijksterhuis WPM; van Putten M; Heuthorst L; de Vos-Geelen JM; Haj Mohammad N; Nieuwenhuijzen GAP; van Laarhoven HWM; Verhoeven RHA
    Gastric Cancer; 2019 Nov; 22(6):1263-1273. PubMed ID: 30949777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
    Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
    World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival After Minimally Invasive vs Open Surgery for Pancreatic Adenocarcinoma.
    Topal H; Aerts R; Laenen A; Collignon A; Jaekers J; Geers J; Topal B
    JAMA Netw Open; 2022 Dec; 5(12):e2248147. PubMed ID: 36547979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features and lymph node metastatic patterns of gastric mixed adenoneuroendocrine carcinoma.
    Chen H; Shu M; Chen S; Xue L; Lin Y
    Histol Histopathol; 2019 Apr; 34(4):373-379. PubMed ID: 30238962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides GA; Fields RC; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
    J Am Coll Surg; 2014 Oct; 219(4):664-75. PubMed ID: 25154671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
    Nie L; Li M; He X; Feng A; Wu H; Fan X
    Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.
    Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M
    Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological Features and Postoperative Survival Analysis of Gastric Carcinoma with Neuroendocrine Differentiation.
    Liu J; Pan X; Sun Y; Dong T; Hu X; Zhong H; Lu J
    J Oncol; 2022; 2022():4440098. PubMed ID: 36035314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
    Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
    Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.